4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-003315
Chief Executive Officer sold 7,800 shares at an average $34.55 ($269,470)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-09 | Sale | −1,900 | $34.51 | $65,569 | 9,978 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-09 | Sale | −2,000 | $35.16 | $70,320 | 7,978 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-10 | Sale | −1,700 | $33.93 | $57,681 | 6,278 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2019-01-10 | Sale | −2,200 | $34.50 | $75,900 | 4,078 | I: show line 4 in the form |
| Open-market sales · 7,800 sh · avg $34.55 · $269,470 | |||||||
Loading xslF345X03/doc4.xml…